Skip to content
Recall Observatory FDA recall evidence

Drug product

Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. UPC 368462583401. NDC 68462-583-40

D-0349-2019

November 27, 2018

Class III

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 81639
Status
Terminated
Classification
Class III
Quantity
5,016 blister packs
Official record key
drug-enforcement:D-0349-2019

Official wording

Reason: Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.

Code information: Lot: 17180918, EXP June 2020

Distribution pattern: Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.